Comprehensive Approach to the Prevention and Management of Maternal Anaemia in Nigeria
CAPREMAN is an implementation research to co-design, test, and develop a comprehensive guideline for screening, prevention and treatment of anaemia during pregnancy and postpartum.
The CAPREMAN study is an implementation research project conducted in selected states across the country to address maternal anaemia – one of the most persistent threats to maternal and newborn health in Nigeria.
Many women in Nigeria face anaemia during pregnancy and postpartum, often without early diagnosis or access to effective treatment. Despite the availability of innovative tools and global best practices, health facilities often lack structured protocols for screening and management. This study builds on previous trials and implementation research (IVON, IVON-PP, and IVON-IS), expanding the scope and applying learning to a broader, more inclusive health system context.
CAPREMAN seeks to close this gap.
Through stakeholder-driven co-design, the study will develop and implement a practical guideline that integrates three key components:
- Hemocue point-of-care testing for early and repeated anaemia screening
- Multiple Micronutrient Supplementation (MMS) for routine prevention
- Ferric Carboxymaltose (FCM) for safe and effective treatment of moderate to severe anaemia
Interested in Participating in CAPREMAN?
We are working with antenatal and postnatal clinics in Lagos, Kano, and Kaduna States. If you are pregnant or recently delivered and receive care at any of our partner health facilities, you may be eligible to join the study.
Sponsored By:
College of Medicine, University of Lagos
Supported By:
Maternal and Reproductive Health Collective (MRH), Lagos Nigeria
Centre for Clinical Trials, Research & Implementation Science